More Details on the Administration’s FDA Budget
The Alliance for a Stronger FDA endorsed the President’s requested increase in FDA’s budget authority (BA) appropriations of $372 million over the FY 2023 appropriated amounts for a proposed total of $3.963 billion. The request is about a 10% increase in BA (taxpayer) funding compared to the FY 23 appropriated level.
The total FDA budget request is for $7.2 billion of which about $4 billion would come from taxpayer funds appropriated by Congress, $2.5 billion from medical products user fees, and $700 million from tobacco user fees.
We will be reviewing the detailed budget request, which is expected early next week and is known as the Congressional Justification (CJ). From that, we will be able to provide additional information about the strengths of the request and any areas in which we think additional emphasis is needed,
In the interim, the most detailed statement of program priorities is this abridged version of FDA’s “highlights of the agency’s request”:
Enhancing Food Safety, Nutrition and Cosmetics
$128.2 million in investments in food safety and nutrition modernization, including food labeling and animal food safety oversight. While the agency is in the process of defining its future vision for the Human Foods Program, there is significant need for additional resources to strengthen its foundational food safety and nutrition capacity.
$5 million toward modernizing oversight of cosmetics. The budget includes new funding for the development of regulations, compliance policies, product registration and listing platforms, adverse event reporting and other activities.
Advancing Access to Safe and Effective Medical Products
$23 million in additional funds to advance the goal of ending the opioid crisis. Funding will support broader development of treatments for substance use disorders and enhance regulatory oversight, expand compliance, enforcement, and laboratory support.
$11.6 million increase toward improving the medical device supply chain and shortage programs. The agency will continue to build its capabilities to ensure patients have access to medical devices at all times.
$2.5 million to implement ACT for ALS to foster development of treatments for ALS and other rare neurodegenerative diseases. To help the FDA implement the ACT for ALS Act.
Reigniting Cancer Moonshot
$50 million to advance the president’s Cancer Moonshot goals. This funding will advance the President’s Cancer Moonshot.
Strengthening Public Health and Mission Support Capacity
$10 million in further investments in enterprise data and IT modernization. The budget will expand data exchange capabilities and underlying technology platforms to better meet the challenges of the FDA’s programs and mission-critical responsibilities.
$16 million for regulatory and mission support functions within the Office of the Commissioner. These resources will enable the FDA to provide the appropriate crosscutting strategic direction, policy coordination, and business services to ensure that the FDA’s programs operate effectively, efficiently, and are well coordinated.
$9.4 million for FDA buildings, facilities, and infrastructure improvements. The budget includes additional funding to help ensure that the FDA’s offices and laboratories across the country are secure, modern, reliable and cost-effective.